Trial Profile
Open-label study of tiotropium/pirfenidone for idiopathic pulmonary fibrosis with emphysema
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Pirfenidone (Primary) ; Tiotropium bromide (Primary)
- Indications Emphysema; Idiopathic pulmonary fibrosis
- Focus Therapeutic Use
- 18 Jun 2011 New trial record